经典与微创手术治疗LUTS/BPH的射精功能保留
本系统综述纳入41项研究,探讨经典内镜手术与微创手术(iTind、Rezūm、Urolift、Aquablation、TPLA)对射精功能的保留情况。所有术式均能改善LUTS/BPH症状(IPSS、QoL、Qmax),部分研究显示射精功能保留的积极结果,但研究设计、队列及长期数据有限带来挑战。综述初步结论认为各MIST在保留射精方面似乎相当,需长期研究验证可持续性。
要点
- 所有术式均能改善IPSS、QoL、Qmax,部分研究显示射精功能保留的积极结果。
- 研究设计、患者队列及长期数据有限,且基线特异性缺乏、alpha受体阻滞剂使用及性功能评估非特异带来偏倚。
- 综述初步认为iTind、Rezūm、Urolift、Aquablation、TPLA在保留射精方面似乎相当。
核心结论
- 尽管存在局限,本综述初步结论认为包括iTind、Rezūm、Urolift、Aquablation和TPLA在内的MIST在保留射精方面似乎相当。
- 需要长期研究验证可持续性,比较研究应评估MIST与传统手术之间的权衡。
- 融入患者报告结局和生活质量评估将提升未来研究,使MIST成为LUTS/BPH的标准治疗选择。
研究设计与样本
- 系统综述,文献检索共纳入41项研究,评估经典内镜手术与微创手术(iTind、Rezūm、Urolift、Aquablation、TPLA)后的射精功能保留情况。
主要发现
- 所有术式均显示改善LUTS/BPH症状(IPSS、QoL、Qmax)的疗效。
- 部分研究评估了射精功能,观察到积极结果,挑战了BPH手术与射精功能障碍的历史关联。
- 研究设计、患者队列及有限长期数据带来挑战;基线特异性缺乏、alpha受体阻滞剂使用及非特异性性功能评估凸显潜在偏倚。
局限性
- 研究设计、患者队列和有限长期数据带来挑战。
- 基线特异性缺乏、alpha受体阻滞剂使用及非特异性性功能评估凸显潜在偏倚。
- 长期研究对验证可持续性至关重要。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The surgical landscape for Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH) has evolved with the introduction of Minimally Invasive Surgical Therapies (MISTs), recognizing the impact of sexual function on patients' well-being, and prioritizing ejaculation-sparing approaches. METHODS: This systematic review explored ejaculation sparing after classic endoscopic procedures and MISTs (iTind, Rezūm, Urolift, Aquablation, and TPLA) and a literature search yielded 41 studies. RESULTS: While all procedures demonstrated efficacy in improving LUTS/BPH symptoms (IPSS, QoL, Qmax), a subset of studies evaluated ejaculatory function. Positive outcomes were noted, challenging the historical association of BPH surgeries with ejaculatory dysfunction. Variations in study design, patient cohorts, and limited long-term data present challenges. Notably, the lack of baseline specificity, use of alpha-blockers, and non-specific sexual function assessments underscore potential biases. CONCLUSIONS: Despite limitations, the review tentatively concluded that MISTs, including iTind, Rezūm, Urolift, Aquablation, and TPLA, appear comparable in sparing ejaculation. Long-term studies are essential to validate sustainability, and comparative research should assess trade-offs between MISTs and traditional surgeries. Incorporating patient-reported outcomes and quality of life assessments will enhance future investigations, refining MISTs as standard therapeutic options for LUTS/BPH.
引用
- Busetto GM, Lombardo R, De Nunzio C, et al. Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH. Prostate Cancer Prostatic Dis. 2024. PMID: 38615071. doi:10.1038/s41391-024-00834-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。